Viatar CTC Solutions Inc. Announces Financial Results for the First Quarter Ended March 31, 2016
Viatar CTC Solutions Inc. announced financial results for the first quarter ended March 31, 2016. For the first quarter of 2016, the company reported $0 sales compared to sales of $9,970 in the comparable quarter of 2015. Total research &development expenses, including clinical and regulatory expenses, were $895,365 compared to $820,655 in the first quarter of 2016 and 2015 respectively. The company reported a net loss of $1,373,351 for the first quarter of 2016 compared to a net loss of $1,116,238 for the comparable period in 2015.